Rosburix(4D Pharma Research)

N/A

Report date: 2022/11/27 16:45:24

Base Information

Drug NameRosburix(4D Pharma Research)
Drug Alias NameN/A
ClassificationBiologicsNatural product/Extract > Microbial extract
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsPediatric ulcerative colitisColitis, UlcerativeGastroenteritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies4d Pharma Plc
China Registration ClassN/A

Develop Information

Active Companies4d Pharma Plc
Inactive CompaniesN/A
Active IndicationsPediatric ulcerative colitisColitis, UlcerativeGastroenteritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A